secwatch.observer — SEC 8-K summary
======================================

Issuer:     GridAI Technologies Corp. (GRDX)
CIK:        0001604191
Form:       8-K
Filed at:   2023-01-17T23:59:59+00:00
Accession:  0001104659-23-004102
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

First Wave BioPharma shareholders approve 1-for-7 reverse stock split; effective Jan 18, 2023
--------------------------------------------------------------------------------

- Stockholders approved 1-for-7 reverse stock split; effective 12:01 AM ET Jan 18, 2023.
- Reverse split reduces outstanding shares from ~6.97M to ~995k shares.
- Also approved issuance of >20% of common stock in private placement from Nov 20, 2022 agreement.
- Board set split ratio at 1:7, within approved range of 1:3 to 1:40.
- No fractional shares issued; holders receive cash for fractional interests.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923004102/0001104659-23-004102-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604191/000110465923004102/tm233436d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-004102

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer